News on ABAXIS from BioPortfolio.com http://www.BioPortfolio.com Consolidated ABAXIS news from BioPortfolio.com Wed, 10 Feb 2010 10:15:22 GMT en 2/7/10 - Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026579&HITNO=0&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026579&THISHREF=http://c.moreover.com/click/here.pl%3fz2530979526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026579&HITNO=0&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026579&THISHREF=http://c.moreover.com/click/here.pl%3fz2530979526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Stocks Advancing Amid Heavy Short Interest - USEC Inc, VistaPrint NV, Thoratec Corp, PDL BioPharma Inc, Enzonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991324&HITNO=1&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991324&THISHREF=http://c.moreover.com/click/here.pl%3fz2513662455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991324&HITNO=1&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991324&THISHREF=http://c.moreover.com/click/here.pl%3fz2513662455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSchaeffers Research: Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978885&HITNO=2&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978885&THISHREF=http://c.moreover.com/click/here.pl%3fz2505516162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978885&HITNO=2&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978885&THISHREF=http://c.moreover.com/click/here.pl%3fz2505516162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946497&HITNO=3&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946497&THISHREF=http://c.moreover.com/click/here.pl%3fz2487573676%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946497&HITNO=3&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946497&THISHREF=http://c.moreover.com/click/here.pl%3fz2487573676%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Abaxis says FDA clears new infection testhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946361&HITNO=4&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946361&THISHREF=http://c.moreover.com/click/here.pl%3fz2487513258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946361&HITNO=4&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946361&THISHREF=http://c.moreover.com/click/here.pl%3fz2487513258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Abaxis gets FDA clearance for CRP testhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949497&HITNO=5&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949497&THISHREF=http://c.moreover.com/click/here.pl%3fz2489156149%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949497&HITNO=5&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949497&THISHREF=http://c.moreover.com/click/here.pl%3fz2489156149%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: 1/21/10 - Abaxis says FDA clears new infection testhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946318&HITNO=6&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946318&THISHREF=http://c.moreover.com/click/here.pl%3fz2487494689%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946318&HITNO=6&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946318&THISHREF=http://c.moreover.com/click/here.pl%3fz2487494689%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Abaxis says FDA clears new infection testhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945769&HITNO=7&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945769&THISHREF=http://c.moreover.com/click/here.pl%3fz2487305682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945769&HITNO=7&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945769&THISHREF=http://c.moreover.com/click/here.pl%3fz2487305682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Abaxis' new CRP assay receives FDA marketing clearancehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941529&HITNO=8&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941529&THISHREF=http://c.moreover.com/click/here.pl%3fz2485479964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941529&HITNO=8&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941529&THISHREF=http://c.moreover.com/click/here.pl%3fz2485479964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945245&HITNO=9&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945245&THISHREF=http://c.moreover.com/click/here.pl%3fz2486995807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945245&HITNO=9&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945245&THISHREF=http://c.moreover.com/click/here.pl%3fz2486995807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: 1/21/10 - Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944867&HITNO=10&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944867&THISHREF=http://c.moreover.com/click/here.pl%3fz2486778915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944867&HITNO=10&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944867&THISHREF=http://c.moreover.com/click/here.pl%3fz2486778915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944689&HITNO=11&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944689&THISHREF=http://c.moreover.com/click/here.pl%3fz2486690097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944689&HITNO=11&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944689&THISHREF=http://c.moreover.com/click/here.pl%3fz2486690097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941486&HITNO=12&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941486&THISHREF=http://c.moreover.com/click/here.pl%3fz2485462001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941486&HITNO=12&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941486&THISHREF=http://c.moreover.com/click/here.pl%3fz2485462001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein / U.S. Healthcare Professionals Now Have Access to Important Information on Inflammation, Infection and Tissue Injury at the Point-of-care.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941205&HITNO=13&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941205&THISHREF=http://c.moreover.com/click/here.pl%3fz2485364568%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941205&HITNO=13&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941205&THISHREF=http://c.moreover.com/click/here.pl%3fz2485364568%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: FDA Clears Abaxis Testing Producthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945181&HITNO=14&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945181&THISHREF=http://c.moreover.com/click/here.pl%3fz2486943248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945181&HITNO=14&MSIZE=17&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ABAXIS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945181&THISHREF=http://c.moreover.com/click/here.pl%3fz2486943248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: